A detailed history of D.A. Davidson & Co. transactions in Dexcom Inc stock. As of the latest transaction made, D.A. Davidson & Co. holds 26,609 shares of DXCM stock, worth $1.79 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
26,609
Previous 35,485 25.01%
Holding current value
$1.79 Million
Previous $4.92 Million 38.71%
% of portfolio
0.03%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$110.31 - $140.45 $979,111 - $1.25 Million
-8,876 Reduced 25.01%
26,609 $3.02 Million
Q1 2024

May 13, 2024

BUY
$114.22 - $140.1 $1,142 - $1,401
10 Added 0.03%
35,485 $4.92 Million
Q4 2023

Feb 09, 2024

BUY
$75.49 - $124.16 $35,102 - $57,734
465 Added 1.33%
35,475 $4.4 Million
Q3 2023

Nov 08, 2023

BUY
$86.06 - $137.93 $811,717 - $1.3 Million
9,432 Added 36.88%
35,010 $3.27 Million
Q2 2023

Aug 10, 2023

SELL
$112.47 - $130.98 $521,973 - $607,878
-4,641 Reduced 15.36%
25,578 $3.29 Million
Q1 2023

Apr 25, 2023

BUY
$104.0 - $122.92 $13,000 - $15,365
125 Added 0.42%
30,219 $3.51 Million
Q4 2022

Feb 03, 2023

SELL
$84.98 - $122.67 $193,414 - $279,196
-2,276 Reduced 7.03%
30,094 $3.41 Million
Q3 2022

Nov 07, 2022

SELL
$76.35 - $94.18 $98,644 - $121,680
-1,292 Reduced 3.84%
32,370 $2.61 Million
Q2 2022

Jul 28, 2022

BUY
$67.99 - $132.89 $1.75 Million - $3.42 Million
25,756 Added 325.78%
33,662 $2.51 Million
Q1 2022

May 12, 2022

SELL
$94.08 - $130.2 $17,592 - $24,347
-187 Reduced 2.31%
7,906 $4.05 Million
Q4 2021

Jan 31, 2022

BUY
$129.87 - $162.82 $5,584 - $7,001
43 Added 0.53%
8,093 $4.35 Million
Q3 2021

Nov 15, 2021

SELL
$106.71 - $143.18 $33,613 - $45,101
-315 Reduced 3.77%
8,050 $4.4 Million
Q2 2021

Aug 10, 2021

BUY
$80.99 - $107.93 $62,767 - $83,645
775 Added 10.21%
8,365 $3.57 Million
Q1 2021

May 07, 2021

BUY
$84.79 - $104.74 $500,600 - $618,384
5,904 Added 350.18%
7,590 $2.73 Million
Q4 2020

Feb 10, 2021

BUY
$78.0 - $104.5 $32,526 - $43,576
417 Added 32.86%
1,686 $623,000
Q3 2020

Nov 02, 2020

BUY
$95.51 - $112.95 $9,742 - $11,520
102 Added 8.74%
1,269 $523,000
Q2 2020

Aug 10, 2020

SELL
$62.68 - $105.34 $254,668 - $427,996
-4,063 Reduced 77.69%
1,167 $473,000
Q1 2020

May 05, 2020

BUY
$47.79 - $75.63 $39,952 - $63,226
836 Added 19.03%
5,230 $1.41 Million
Q4 2019

Feb 14, 2020

SELL
$36.62 - $57.29 $22,997 - $35,978
-628 Reduced 12.5%
4,394 $961,000
Q3 2019

Nov 05, 2019

SELL
$35.53 - $43.8 $1,598 - $1,970
-45 Reduced 0.89%
5,022 $749,000
Q2 2019

Aug 13, 2019

BUY
$27.84 - $38.92 $5,568 - $7,784
200 Added 4.11%
5,067 $759,000
Q1 2019

May 13, 2019

SELL
$28.07 - $38.18 $21,754 - $29,589
-775 Reduced 13.74%
4,867 $580,000
Q4 2018

Jan 29, 2019

BUY
$26.99 - $37.37 $56,975 - $78,888
2,111 Added 59.78%
5,642 $676,000
Q3 2018

Nov 13, 2018

SELL
$23.35 - $36.72 $4,646 - $7,307
-199 Reduced 5.34%
3,531 $505,000
Q2 2018

Aug 02, 2018

BUY
$17.54 - $25.22 $877 - $1,261
50 Added 1.36%
3,730 $354,000
Q1 2018

May 04, 2018

BUY
$13.06 - $18.54 $653 - $927
50 Added 1.38%
3,680 $273,000
Q4 2017

Feb 08, 2018

BUY
$11.12 - $15.38 $40,365 - $55,829
3,630 New
3,630 $208,000
Q3 2017

Nov 08, 2017

SELL
$11.36 - $18.98 $36,920 - $61,685
-3,250 Closed
0 $0
Q2 2017

Aug 11, 2017

BUY
N/A
3,250
3,250 $0

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track D.A. Davidson & Co. Portfolio

Follow D.A. Davidson & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.